Antibiotics Active Pharmaceutical Ingredient (API) Market Report

China Antibiotics Active Pharmaceutical Ingredient (API) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 27, 2023
  • PAGES：151
  • REPORT CODE：GMM1816244
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Antibiotics Active Pharmaceutical Ingredient (API) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ACS DOBFAR SPA

    • Nanjing Dorra Pharmaceutical Technology Co Ltd

    • DAEWOONG PHARMACEUTICAL CO LTD

    • Parabolic Drugs Ltd

    • Unimark Remedies Ltd

    • ASIATIC DRUGS & PHARMACEUTICALS PVT LTD

    • Sandoz International GmbH

    • Penam Laboratories Ltd

    • Centrient Pharmaceuticals

    • Aurobindo Pharma Limited

    • Fresenius Kabi

    By Type:

    • Imipenem

    • Cephalosporins

    • Carbapenem Antibiotics

    • Meropenem

    • Benzathine

    • Cefuroxime

    • Cefalotin

    • Dicloxacillin

    • Ampicillin

    • Cefotaxime

    • Penicillin Antibiotics

    • Ertapenem

    • Penicillin G Sodium

    • Amoxicillin

    • Ceftriaxone

    • Procaine

    By Application:

    • Pharmaceutical Companies

    • Contract Development & Manufacturing Organizations (CDMOs)

    • Contract Manufacturing Organizations (CMOs)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Antibiotics Active Pharmaceutical Ingredient (API) Market Overview 2018-2029

    • 1.1 China Antibiotics Active Pharmaceutical Ingredient (API) Industry Development Overview

    • 1.2 China Antibiotics Active Pharmaceutical Ingredient (API) Industry Development History

    • 1.3 China Antibiotics Active Pharmaceutical Ingredient (API) Industry Market Size (2018-2029)

    • 1.4 China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis by Type from Production Side

      • 1.4.1 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Imipenem (2018-2029)

      • 1.4.2 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cephalosporins (2018-2029)

      • 1.4.3 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Carbapenem Antibiotics (2018-2029)

      • 1.4.4 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Meropenem (2018-2029)

      • 1.4.5 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Benzathine (2018-2029)

      • 1.4.6 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefuroxime (2018-2029)

      • 1.4.7 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefalotin (2018-2029)

      • 1.4.8 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Dicloxacillin (2018-2029)

      • 1.4.9 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ampicillin (2018-2029)

      • 1.4.10 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefotaxime (2018-2029)

      • 1.4.11 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Penicillin Antibiotics (2018-2029)

      • 1.4.12 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ertapenem (2018-2029)

      • 1.4.13 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Penicillin G Sodium (2018-2029)

      • 1.4.14 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Amoxicillin (2018-2029)

      • 1.4.15 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ceftriaxone (2018-2029)

      • 1.4.16 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Procaine (2018-2029)

    • 1.5 China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis by Application from Consumption End

      • 1.5.1 China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

      • 1.5.2 China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Contract Development & Manufacturing Organizations (CDMOs) (2018-2029)

      • 1.5.3 China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Contract Manufacturing Organizations (CMOs) (2018-2029)

    • 1.6 China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis by Region

      • 1.6.1 North China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Antibiotics Active Pharmaceutical Ingredient (API) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Antibiotics Active Pharmaceutical Ingredient (API) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Antibiotics Active Pharmaceutical Ingredient (API) Market Status and Competition Analysis in 2023

      • 2.2.3 China Antibiotics Active Pharmaceutical Ingredient (API) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Antibiotics Active Pharmaceutical Ingredient (API) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Antibiotics Active Pharmaceutical Ingredient (API) Industry Development

    Chapter 3 Antibiotics Active Pharmaceutical Ingredient (API)Industry Chain Analysis

    • 3.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Chain

    • 3.2 Antibiotics Active Pharmaceutical Ingredient (API) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Antibiotics Active Pharmaceutical Ingredient (API) Market

    • 3.3 Antibiotics Active Pharmaceutical Ingredient (API) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Antibiotics Active Pharmaceutical Ingredient (API) Market

    Chapter 4 China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 4.1 China Antibiotics Active Pharmaceutical Ingredient (API) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Antibiotics Active Pharmaceutical Ingredient (API) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate, by Type

      • 4.5.1 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Imipenem

      • 4.5.2 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cephalosporins

      • 4.5.3 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Carbapenem Antibiotics

      • 4.5.4 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Meropenem

      • 4.5.5 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Benzathine

      • 4.5.6 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefuroxime

      • 4.5.7 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefalotin

      • 4.5.8 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Dicloxacillin

      • 4.5.9 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ampicillin

      • 4.5.10 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefotaxime

      • 4.5.11 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Penicillin Antibiotics

      • 4.5.12 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ertapenem

      • 4.5.13 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Penicillin G Sodium

      • 4.5.14 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Amoxicillin

      • 4.5.15 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ceftriaxone

      • 4.5.16 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Procaine

    Chapter 5 China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Antibiotics Active Pharmaceutical Ingredient (API) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate, by Application

      • 5.5.1 China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Pharmaceutical Companies

      • 5.5.2 China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Contract Development & Manufacturing Organizations (CDMOs)

      • 5.5.3 China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Contract Manufacturing Organizations (CMOs)

    Chapter 6 China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Region

    • 6.1 China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Production Value, by Region

    • 6.2 China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume and Sales Value, by Region

    Chapter 7 North China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 7.1 North China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 7.2 North China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 8 Central China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 8.1 Central China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 8.2 Central China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 9 South China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 9.1 South China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 9.2 South China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 10 East China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 10.1 East China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 10.2 East China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 11 Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 11.1 Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 11.2 Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 12 Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 12.1 Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 12.2 Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 13 Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis

    • 13.1 Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type

    • 13.2 Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ACS DOBFAR SPA

        • 14.1.1 ACS DOBFAR SPA Company Profile

        • 14.1.2 ACS DOBFAR SPA Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Nanjing Dorra Pharmaceutical Technology Co Ltd

        • 14.2.1 Nanjing Dorra Pharmaceutical Technology Co Ltd Company Profile

        • 14.2.2 Nanjing Dorra Pharmaceutical Technology Co Ltd Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 DAEWOONG PHARMACEUTICAL CO LTD

        • 14.3.1 DAEWOONG PHARMACEUTICAL CO LTD Company Profile

        • 14.3.2 DAEWOONG PHARMACEUTICAL CO LTD Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Parabolic Drugs Ltd

        • 14.4.1 Parabolic Drugs Ltd Company Profile

        • 14.4.2 Parabolic Drugs Ltd Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Unimark Remedies Ltd

        • 14.5.1 Unimark Remedies Ltd Company Profile

        • 14.5.2 Unimark Remedies Ltd Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 ASIATIC DRUGS & PHARMACEUTICALS PVT LTD

        • 14.6.1 ASIATIC DRUGS & PHARMACEUTICALS PVT LTD Company Profile

        • 14.6.2 ASIATIC DRUGS & PHARMACEUTICALS PVT LTD Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sandoz International GmbH

        • 14.7.1 Sandoz International GmbH Company Profile

        • 14.7.2 Sandoz International GmbH Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Penam Laboratories Ltd

        • 14.8.1 Penam Laboratories Ltd Company Profile

        • 14.8.2 Penam Laboratories Ltd Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Centrient Pharmaceuticals

        • 14.9.1 Centrient Pharmaceuticals Company Profile

        • 14.9.2 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Aurobindo Pharma Limited

        • 14.10.1 Aurobindo Pharma Limited Company Profile

        • 14.10.2 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Fresenius Kabi

        • 14.11.1 Fresenius Kabi Company Profile

        • 14.11.2 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Research Conclusions

    • 15.2 Antibiotics Active Pharmaceutical Ingredient (API) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Industry Market Size (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Imipenem (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cephalosporins (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Carbapenem Antibiotics (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Meropenem (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Benzathine (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefuroxime (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefalotin (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Dicloxacillin (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ampicillin (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Cefotaxime (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Penicillin Antibiotics (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ertapenem (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Penicillin G Sodium (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Amoxicillin (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Ceftriaxone (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume, Production Value and Growth Rate of Procaine (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Contract Development & Manufacturing Organizations (CDMOs) (2018-2029)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume, Sales Value and Growth Rate of Contract Manufacturing Organizations (CMOs) (2018-2029)

    • Figure North China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure Central China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure South China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure East China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate from 2018-2029

    • Figure Antibiotics Active Pharmaceutical Ingredient (API) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Type in 2018

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Type in 2023

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Imipenem (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cephalosporins (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Carbapenem Antibiotics (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Meropenem (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Benzathine (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefuroxime (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefalotin (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Dicloxacillin (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ampicillin (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Cefotaxime (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Penicillin Antibiotics (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ertapenem (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Penicillin G Sodium (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Amoxicillin (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Ceftriaxone (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume and Growth Rate of Procaine (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Application in 2018

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Application in 2023

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Total Market Size and Growth Rate from Consumption End

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Pharmaceutical Companies (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Contract Development & Manufacturing Organizations (CDMOs) (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Market Size and Growth Rate of Contract Manufacturing Organizations (CMOs) (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Region (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Production Value by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Production Value Share by Region (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Production Value Share by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Region (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Sales Value by Region (2018-2023)

    • Table China Antibiotics Active Pharmaceutical Ingredient (API) Sales Value Share by Region (2018-2023)

    • Figure China Antibiotics Active Pharmaceutical Ingredient (API) Sales Value Share by Region (2018-2023)

    • Table North China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table North China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure North China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table North China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table North China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure North China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table Central China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table Central China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure Central China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table Central China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table Central China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure Central China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table South China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table South China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure South China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table South China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table South China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure South China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table East China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table East China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure East China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table East China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table East China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure East China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume by Type (2018-2023)

    • Table Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Production Volume Share by Type (2018-2023)

    • Table Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume by Application (2018-2023)

    • Table Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Antibiotics Active Pharmaceutical Ingredient (API) Sales Volume Share by Application (2018-2023)

    • Table ACS DOBFAR SPA Company Profile

    • Table ACS DOBFAR SPA Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Nanjing Dorra Pharmaceutical Technology Co Ltd Company Profile

    • Table Nanjing Dorra Pharmaceutical Technology Co Ltd Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table DAEWOONG PHARMACEUTICAL CO LTD Company Profile

    • Table DAEWOONG PHARMACEUTICAL CO LTD Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Parabolic Drugs Ltd Company Profile

    • Table Parabolic Drugs Ltd Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Unimark Remedies Ltd Company Profile

    • Table Unimark Remedies Ltd Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table ASIATIC DRUGS & PHARMACEUTICALS PVT LTD Company Profile

    • Table ASIATIC DRUGS & PHARMACEUTICALS PVT LTD Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Sandoz International GmbH Company Profile

    • Table Sandoz International GmbH Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Penam Laboratories Ltd Company Profile

    • Table Penam Laboratories Ltd Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Centrient Pharmaceuticals Company Profile

    • Table Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Aurobindo Pharma Limited Company Profile

    • Table Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)

    • Table Fresenius Kabi Company Profile

    • Table Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US